Sunday
2:00 pm - 9:00 pm
Arrival and Check-in
6:00 pm - 7:00 pm
Dinner
7:30 pm - 7:40 pm
Introductory Comments by GRC Site Staff / Welcome from the GRC Chair
7:40 pm - 9:30 pm
Keynote Session: The Impact of Chemical Biology in Drug Discovery
Discussion Leader: Brian Shoichet (University of California, San Francisco, USA)
7:40 pm - 8:25 pm
Benjamin Cravatt (The Scripps Research Institute, USA)
"Activity-Based Proteomics: Protein and Ligand Discovery on a Global Scale"
8:25 pm - 8:35 pm
Discussion
8:35 pm - 9:20 pm
Angela Koehler (Massachusetts Institute of Technology, USA)
"Small-Molecule Control of Transcription"
9:20 pm - 9:30 pm
Discussion
Monday
7:30 am - 8:30 am
Breakfast
9:00 am - 12:30 pm
Chemical Matter Diversity for Probes and Therapeutics
Discussion Leader: Sam Gerritz (Halda Therapeutics, USA)
9:00 am - 9:05 am
Introduction by Discussion Leader
9:05 am - 9:35 am
Damian Young (Baylor College of Medicine, USA)
"New Synthetic and Biophysical Methodologies in Fragment-Based Cancer Drug Discovery"
9:35 am - 9:40 am
Discussion
9:40 am - 10:10 am
Yun Ding (GlaxoSmithKline, USA)
"Expanding DNA-Encoded Library Chemical and Target Space with Novel Chemistries"
10:10 am - 10:15 am
Discussion
10:15 am - 10:45 am
Coffee Break
10:45 am - 11:15 am
Arturo Vegas (Boston University, USA)
"Chemical Tools to Understand Mechanisms that Control the Physiological Distribution of Therapeutics"
11:15 am - 11:20 am
Discussion
11:20 am - 11:50 am
M. Eugenio Vazquez (University of Santiago de Compostela, Spain)
"DNA Recognition and Sensing with Designed Metal Complexes"
11:50 am - 11:55 am
Discussion
11:55 am - 12:25 pm
Xiang David Li (The University of Hong Kong, Hong Kong SAR China)
"Photo-Affinity Probes to Interrogate Protein-Protein and Protein-Drug Interactions"
12:25 pm - 12:30 pm
Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:00 pm
Free Time
3:00 pm - 4:00 pm
The GRC Power Hourâ„¢
The GRC Power Hourâ„¢ is designed to address challenges women face in science and issues of diversity and inclusion. The program supports the professional growth of all members of our communities by providing an open forum for discussion and mentoring.
Organizers: Christine Kaiser (Merck, USA) and Lisa Marcaurelle (GlaxoSmithKline, USA)
4:00 pm - 6:00 pm
Poster Session
6:00 pm - 7:00 pm
Dinner
7:30 pm - 9:30 pm
Novel Chemistries and Reaction Scouting
Discussion Leader: Damian Young (Baylor College of Medicine, USA)
7:30 pm - 7:35 pm
Introduction by Discussion Leader
7:35 pm - 8:05 pm
Monica Perez-Temprano (Institute of Chemical Research of Catalonia, Spain)
"Synergistic Cooperation Between Mechanistic Investigation and Catalysis: Towards Rational Design"
8:05 pm - 8:10 pm
Discussion
8:10 pm - 8:40 pm
Masayuki Wasa (Boston College, USA)
"Recent Advances in Frustrated Acid/Base Complexes as Potential Cooperative Catalysts for Practical Synthetic Transformations"
8:40 pm - 8:45 pm
Discussion
8:45 pm - 8:55 pm
Leslie Aldrich (University of Illinois at Chicago, USA)
"Discovery of Novel, Small-Molecule Autophagy Inhibitors Through Phenotypic and Target-Based Approaches"
8:55 pm - 9:00 pm
Discussion
9:00 pm - 9:10 pm
Eli Chapman (University of Arizona, USA)
"Modulation of NRF2 in Chemoprevention and Cancer Therapy"
9:10 pm - 9:15 pm
Discussion
9:15 pm - 9:25 pm
Louis Conway (Uppsala University, Sweden)
"Chemical Probes with a Unique Bioorthogonal Cleavage Site for Improved Metabolomic Analysis"
9:25 pm - 9:30 pm
Discussion
Tuesday
7:30 am - 8:30 am
Breakfast
9:00 am - 12:30 pm
Chemical Probes and Cellular Assays for Upcoming Druggable Targets
Discussion Leader: Christine Kaiser (Merck, USA)
9:00 am - 9:10 am
Introduction by Discussion Leader
9:10 am - 9:40 am
Andrea Rentmeister (University of Münster, Germany)
"Emerging Chemical Labeling Methods to Analyze and Control RNA"
9:40 am - 9:45 am
Discussion
9:45 am - 10:15 am
Marie Schwinn (Promega Corporation, USA)
"CRISPR-Mediated Tagging of Endogenous Proteins with a Luminescent Peptide to Quantitate Expression Dynamics"
10:15 am - 10:20 am
Discussion
10:20 am - 10:50 am
Group Photo / Coffee Break
10:50 am - 11:20 am
Olugbeminiyi Fadeyi (Merck Exploratory Science Center Cambridge, USA)
"Mapping of Immunomodulatory Receptor Protein Interactions via Photocatalytic-Based Proximity Labeling of the Cell Surface"
11:20 am - 11:25 am
Discussion
11:25 am - 11:55 am
Akane Kawamura (University of Oxford, United Kingdom)
"Chemical Probes to Study Epigenetic Regulation by Histone Demethylases in Health and Disease"
11:55 am - 12:00 pm
Discussion
12:00 pm - 12:10 pm
Debobrato Das (Novartis Institutes for Biomedical Research, USA)
"Bioinformatics-Guided Phenotypic Screen Discovers an AKR Prodrug to Target Oncogenic Transcription Factor Driven Lung Cancers"
12:10 pm - 12:15 pm
Discussion
12:15 pm - 12:25 pm
Martin Reynders (New York University, USA)
"Photoswitchable Chimeras Enable Optical Control of Targeted Protein Degradation"
12:25 pm - 12:30 pm
Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:00 pm
Free Time
4:00 pm - 6:00 pm
Poster Session
6:00 pm - 7:00 pm
Dinner
7:30 pm - 9:30 pm
High Throughput Experimentation in Chemistry and Chemical Biology
Discussion Leader: Lisa Marcaurelle (GlaxoSmithKline, USA)
7:30 pm - 8:00 pm
Amanda Dombrowski (AbbVie, USA)
"Enabling and Accelerating Drug Discovery with High Throughput Technologies"
8:00 pm - 8:05 pm
Discussion
8:05 pm - 8:35 pm
David Kokel (University of California, San Francisco, USA)
"Zebrafish Behavioral Profiling for Neuroactive Drug Discovery"
8:35 pm - 8:40 pm
Discussion
8:40 pm - 8:50 pm
Anam Shaikh (University of Texas Southwestern Medical Center, USA)
"Functional Signature Ontology (FUSION) Mapping for Rapid Mechanism of Action Discovery"
8:50 pm - 8:55 pm
Discussion
8:55 pm - 9:05 pm
Wesley Cochrane (The Scripps Research Institute, USA)
"Activity-Based DNA-Encoded Library Screening"
9:05 pm - 9:10 pm
Discussion
9:10 pm - 9:20 pm
Damien Duveau (National Institutes of Health, USA)
"Discovery of Small Molecule Inhibitors of SIRPa-CD47 Interaction"
9:20 pm - 9:25 pm
Discussion
9:25 pm - 9:30 pm
General Discussion
Wednesday
7:30 am - 8:30 am
Breakfast
9:00 am - 12:30 pm
Computational Methods and Machine Learning in Target Identification and Structure-Activity Relationships
Discussion Leader: David Kokel (University of California, San Francisco, USA)
9:00 am - 9:05 am
Introduction by Discussion Leader
9:05 am - 9:35 am
Brian Shoichet (University of California, San Francisco, USA)
"Ultra-Large Library Docking for Novel Ligand Discovery"
9:35 am - 9:40 am
Discussion
9:40 am - 10:10 am
Ola Engkvist (AstraZeneca, Sweden)
"Applications of Artificial Intelligence-Driven Molecular Design in Drug Discovery Projects"
10:10 am - 10:15 am
Discussion
10:15 am - 10:45 am
Coffee Break
10:45 am - 11:15 am
Anne Mai Wassermann (Merck and Co., USA)
"Informatics-Enabled Early Drug Discovery: From Screening Collection Design to Omics Data Integration"
11:15 am - 11:20 am
Discussion
11:20 am - 11:50 am
Abraham Heifets (Atomwise, Inc., USA)
"Lessons from the Largest Prospective Study of Machine Learning for Hit Discovery"
11:50 am - 11:55 am
Discussion
11:55 am - 12:25 pm
Tudor Oprea (University of New Mexico, USA)
"The Use of Machine Learning for Target and Drug Discovery"
12:25 pm - 12:30 pm
Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:00 pm
Free Time
4:00 pm - 6:00 pm
Poster Session
6:00 pm - 7:00 pm
Dinner
7:00 pm - 7:30 pm
Business Meeting
Nominations for the Next Vice Chair; Fill in Conference Evaluation Forms; Discuss Future Site and Scheduling Preferences; Election of the Next Vice Chair
7:30 pm - 9:30 pm
Omics-Enabled Chemical Biology and Drug Discovery
Discussion Leader: Angela Koehler (Massachusetts Institute of Technology, USA)
7:30 pm - 7:40 pm
Introduction by Discussion Leader
7:40 pm - 8:10 pm
Christina Woo (Harvard University, USA)
"Multiplexed Parallelization of Binding Site Hotspot Mapping"
8:10 pm - 8:15 pm
Discussion
8:15 pm - 8:45 pm
Amit Choudhary (Harvard Medical School / Brigham and Women's Hospital / Broad Institute of MIT and Harvard, USA)
"Small-Molecule Inhibitors, Degraders and Activators of CRISPR-Associated Nucleases"
8:45 pm - 8:50 pm
Discussion
8:50 pm - 9:20 pm
Adam Rabalski (AbbVie, USA)
"Novel and Optimized Chemoproteomic Methods for Identifying and Mapping Small Molecule-Protein Interactomes"
9:20 pm - 9:25 pm
Discussion
9:25 pm - 9:30 pm
General Discussion
Thursday
7:30 am - 8:30 am
Breakfast
9:00 am - 12:30 pm
Exploring Protein Homeostasis to Expand the Druggable Proteome
Discussion Leader: Christina Woo (Harvard University, USA)
9:00 am - 9:10 am
Introduction by Discussion Leader
9:10 am - 9:40 am
Alessio Ciulli (University of Dundee, United Kingdom)
"Structure-Based PROTAC Design"
9:40 am - 9:50 am
Discussion
9:50 am - 10:20 am
Jacob Jaffe (Broad Institute of MIT and Harvard, USA)
"Proteomic Connectivity Maps for Characterization and Targeting of Drugs"
10:20 am - 10:30 am
Discussion
10:30 am - 11:00 am
Coffee Break
11:00 am - 11:30 am
Roman Zubarev (Karolinska Institutet, Sweden)
"High-Throughput Chemical Proteomics for Chemical Biology"
11:30 am - 11:40 am
Discussion
11:40 am - 11:55 am
Darci Trader (Purdue University, USA)
"Drugging the Core Particle of the Proteasome to Increase Protein Degradation Rates"
11:55 am - 12:00 pm
Discussion
12:00 pm - 12:15 pm
Fleur Ferguson (Dana-Farber Cancer Institute, USA)
"Targeted Degradation of Aberrant Tau in Frontotemporal Dementia Patient-Derived Neuronal Cell Models"
12:15 pm - 12:20 pm
Discussion
12:20 pm - 12:30 pm
General Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:00 pm
Free Time
4:00 pm - 6:00 pm
Poster Session
6:00 pm - 7:00 pm
Dinner
7:30 pm - 9:30 pm
Keynote Session: New Mechanisms of Action in Therapeutics
Discussion Leader: Ann Rowley (AbbVie, USA)
7:30 pm - 8:15 pm
Emily Derbyshire (Duke University, USA)
"Chemical Tools for Unraveling Parasite Biology"
8:15 pm - 8:25 pm
Discussion
8:25 pm - 9:10 pm
Kapil Ramachandran (Harvard Medical School, USA)
"Insights in the Membrane-Bound Proteasome in Health and Disease"
9:10 pm - 9:20 pm
Discussion
9:20 pm - 9:30 pm
Closing Remarks
Friday
7:30 am - 8:30 am
Breakfast
9:00 am
Departure